Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Fraxiparin"'
Autor:
N. Manresa Ramón, Mª D. Nájera Pérez, Mª Ángeles Page del Pozo, I. Sánchez Martínez, Mª del M. Sánchez Catalicio, V. Roldán Schilling
Publikováno v:
Farmacia Hospitalaria, Vol 38, Iss 2, Pp 135-144 (2014)
Low-molecular weight (LMW) heparins bring a series of advantages as compared to non-fractionated heparin (NFH), such as safety, efficacy, bioavailability, fewer monitoring, and persistent anti-coagulant response. There exist, however, a concern about
Externí odkaz:
https://doaj.org/article/51e76b80d7764dce870a8d5e952fa144
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 5, Iss 5, Pp 41-45 (2006)
Aim. To study antiaggregant therapy effects in patients with instable angina (UA) and non-Q wave myocardial infarction (non-Q MI). Material and methods. This randomized, open, comparative study included 78 patients with Class IIID UA and non-Q MI. Gr
Externí odkaz:
https://doaj.org/article/dff6a389792e42afb8706e67bc4645f1
Autor:
Florian Wilhelmy, Michael Gaier, Michael Karl Fehrenbach, Johannes Kasper, Jürgen Meixensberger, Rene Oesemann, Annika Hantsche, Dirk Lindner
Background An outbreak of African swine fever (ASF) in China in 2020 has led to an unprecedented shortage of fraxiparin. Most patients, especially those kept in hospital for surgery, are currently treated with prophylactic anticoagulation (AC). In se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::614a388857cfb1fa4d0d49497e940cc4
https://doi.org/10.20944/preprints202104.0312.v1
https://doi.org/10.20944/preprints202104.0312.v1
Publikováno v:
Онкогинекология. :55-63
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32f4da05dabb6dad20c38dd98e651943
https://doi.org/10.52313/22278710_2018_3_55
https://doi.org/10.52313/22278710_2018_3_55
Publikováno v:
Fibrinolytic and Antithrombotic Therapy : Theory, Practice, and Management, 2006.
Externí odkaz:
https://doi.org/10.1093/oso/9780195155648.003.0020
Autor:
Mirgorod Central Clinic, A. Frolov
Publikováno v:
Oftalmologicheskii Zhurnal. 22:54-57
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::753906de04ce68d51088aad710c4c26f
https://doi.org/10.31288/oftalmolzh200965457
https://doi.org/10.31288/oftalmolzh200965457
Autor:
L. Venger
Publikováno v:
Oftalmologicheskii Zhurnal. 22:49-54
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afb6996525a784b182287a43f106dd77
https://doi.org/10.31288/oftalmolzh200964954
https://doi.org/10.31288/oftalmolzh200964954
Autor:
N. Manresa Ramón, Mª D. Nájera Pérez, Mª Ángeles Page del Pozo, I. Sánchez Martínez, Mª del M. Sánchez Catalicio, V. Roldán Schilling
Publikováno v:
Farmacia Hospitalaria, Volume: 38, Issue: 2, Pages: 135-144, Published: APR 2014
Farmacia Hospitalaria, Vol 38, Iss 2, Pp 135-144 (2014)
Farmacia Hospitalaria, Vol 38, Iss 2, Pp 135-144 (2014)
Las HBPMs (heparina de bajo peso molecular) tienen numerosas ventajas sobre la heparina no fraccionada (HNF) como seguridad, eficacia, biodisponibilidad, menor monitorización y una respuesta anticoagulante persistente. Pero, existe cierta preocupaci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::56adc16f16bcb86e8cf9c1fbad72de7c
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432014000200010&lng=en&tlng=en
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432014000200010&lng=en&tlng=en
Publikováno v:
Вестник Российского университета дружбы народов. Серия: Медицина.
Проанализированы результаты лечения 226 пациентов с острым необструктивным пиелонефритом в возрасте от 16 до 74 лет. Проведена сравнитель
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2806::f4412852861d8288ce8b9c2d19b459bf
http://cyberleninka.ru/article_covers/14228276.png
http://cyberleninka.ru/article_covers/14228276.png
Publikováno v:
Bulletin of Experimental Biology and Medicine. 116:1265-1267
A new previously unknown activity of the low molecular-weight heparin Fraxiparin (Sanofi) has been discovered. This is its ability to reduce the plasma clotting action of snake venom coagulases at final concentration of more than 12.5 anti-Xa U/ml, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0e0b7774b75b2e73398b579b2354089
https://doi.org/10.1007/bf00802851
https://doi.org/10.1007/bf00802851